Expression of RPS19 in melanoma - The Human Protein Atlas

MELANOMA - Interactive survival scatter plotⁱ

The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.

The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".

Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.

Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.

& Survival analysisⁱ

RPS19 is not prognostic in melanoma

Stage:

Survival analysis

Current cut offⁱ:
Best expression cut offⁱ: 226.99
Median expressionⁱ: N/A
Median follow up timeⁱ: N/A
P scoreⁱ N/A
3-year survival highⁱ N/A
3-year survival lowⁱ N/A

TCGA RNA samplesⁱ

Average FPKM

276.8

Number of samples

102

Samples

Sample	Description	FPKM
TCGA-XV-A9VZ-01A	90 years, female, white, stage:ii, alive, 11 days	794.7
TCGA-D9-A4Z3-01A	73 years, female, white, stage:iiic, alive, 505 days	773.4
TCGA-EB-A41B-01A	76 years, female, white, stage:iic, alive, 291 days	636.7
TCGA-EB-A5UM-01A	48 years, female, white, stage:iic, alive, 779 days	628.5
TCGA-ER-A42H-01A	77 years, male, white, dead, 426 days	610.7
TCGA-XV-AAZY-01A	76 years, female, white, stage:iiic, alive, 405 days	554.2
TCGA-BF-A9VF-01A	77 years, male, white, stage:iic, alive, 440 days	551.2
TCGA-EB-A3XE-01A	77 years, female, white, stage:iia, alive, 180 days	530.9
TCGA-EB-A4OZ-01A	42 years, female, white, stage:iiic, alive, 620 days	530.8
TCGA-EB-A553-01A	62 years, male, white, stage:iic, alive, 226 days	526.1
TCGA-DA-A960-01A	73 years, male, white, stage:iib, alive, 804 days	515.3
TCGA-BF-AAP8-01A	58 years, male, white, stage:iic, alive, 447 days	485.6
TCGA-BF-A5EO-01A	65 years, male, white, stage:iic, alive, 703 days	484.3
TCGA-EB-A82B-01A	58 years, female, asian, stage:iii, alive, 390 days	472.0
TCGA-ER-A2NF-01A	53 years, male, white, stage:iiib, dead, 877 days	465.7
TCGA-IH-A3EA-01A	61 years, male, white, stage:iic, alive, 524 days	454.9
TCGA-D3-A5GT-01A	43 years, male, white, stage:iiic, alive, 487 days	439.2
TCGA-EB-A4IQ-01A	42 years, female, asian, stage:iiib, dead, 636 days	422.2
TCGA-EB-A85J-01A	66 years, female, white, stage:iib, alive, 360 days	401.1
TCGA-EB-A4XL-01A	56 years, female, white, stage:iic, alive, 777 days	398.1
TCGA-BF-AAP2-01A	62 years, male, white, stage:iib, alive, 405 days	396.9
TCGA-EB-A4P0-01A	82 years, male, white, stage:iic, dead, 326 days	393.6
TCGA-BF-AAP7-01A	76 years, female, white, stage:iic, alive, 318 days	382.4
TCGA-XV-AAZW-01A	62 years, female, white, stage:ii, dead, 393 days	370.6
TCGA-ER-A194-01A	77 years, male, white, dead, 1354 days	352.1
TCGA-EB-A3HV-01A	37 years, male, white, stage:iic, alive, 39 days	334.9
TCGA-BF-A5EP-01A	75 years, female, white, stage:iiic, alive, 335 days	318.7
TCGA-BF-A5ER-01A	63 years, male, white, stage:iic, alive, 327 days	316.5
TCGA-BF-AAOX-01A	83 years, male, white, stage:iic, alive, 444 days	314.5
TCGA-EB-A5SE-01A	73 years, male, white, stage:iib, dead, 401 days	310.2
TCGA-ER-A19T-01A	51 years, male, white, stage:iv, dead, 270 days	305.0
TCGA-EB-A550-01A	75 years, female, white, stage:iic, dead, 264 days	304.1
TCGA-ER-A2NB-01A	57 years, male, white, stage:iiib, dead, 857 days	301.5
TCGA-BF-A1PU-01A	46 years, female, white, stage:iic, alive, 387 days	282.3
TCGA-BF-AAP1-01A	86 years, male, white, stage:iic, alive, 409 days	277.7
TCGA-XV-AAZV-01A	56 years, female, white, stage:ii, alive, 412 days	274.5
TCGA-EB-A85I-01A	66 years, male, white, stage:iic, alive, 362 days	273.9
TCGA-EB-A3Y7-01A	86 years, female, white, stage:iiib, dead, 326 days	270.3
TCGA-YG-AA3N-01A	67 years, male, stage:iic, alive, 306 days	269.6
TCGA-GN-A8LN-01A	68 years, male, white, stage:iic, alive, 772 days	260.5
TCGA-D9-A4Z2-01A	50 years, male, white, stage:iiic, dead, 190 days	260.1
TCGA-EB-A299-01A	63 years, male, white, stage:iia, alive, 378 days	257.7
TCGA-EB-A5VU-01A	56 years, male, asian, stage:iiib, dead, 321 days	257.2
TCGA-BF-AAOU-01A	73 years, female, white, stage:iic, alive, 476 days	256.5
TCGA-ER-A196-01A	64 years, female, white, stage:iic, alive, 1785 days	252.7
TCGA-BF-A5EQ-01A	63 years, male, white, stage:iic, alive, 323 days	249.6
TCGA-EB-A97M-01A	66 years, male, white, stage:iic, alive, 414 days	248.7
TCGA-EB-A82C-01A	70 years, female, asian, stage:iic, alive, 17 days	247.1
TCGA-XV-A9W2-01A	81 years, male, white, stage:i, alive, 417 days	245.1
TCGA-EB-A6QZ-01A	76 years, female, white, stage:iia, dead, 352 days	241.6
TCGA-BF-A1PX-01A	56 years, male, white, stage:iiib, dead, 282 days	235.3
TCGA-EB-A42Y-01A	73 years, female, asian, stage:iic, dead, 721 days	234.7
TCGA-GF-A2C7-01A	48 years, male, white, stage:iic, alive, 21 days	233.8
TCGA-EB-A57M-01A	56 years, male, asian, stage:iiib, dead, 472 days	227.8
TCGA-HR-A5NC-01A	90 years, female, alive, 1000 days	226.1
TCGA-BF-A3DL-01A	84 years, female, white, stage:iiib, alive, 769 days	224.0
TCGA-EB-A3XC-01A	74 years, male, white, stage:iic, alive, 650 days	219.4
TCGA-EB-A6R0-01A	58 years, female, white, stage:iic, dead, 608 days	218.6
TCGA-GF-A769-01A	39 years, male, white, stage:iic, dead, 1070 days	215.9
TCGA-ER-A19K-01A	79 years, female, white, stage:iic, dead, 469 days	211.2
TCGA-EB-A3XD-01A	53 years, female, white, stage:iic, alive, 1160 days	210.4
TCGA-BF-A1PV-01A	74 years, female, white, stage:iic, alive, 14 days	210.3
TCGA-EB-A5SF-01A	78 years, female, white, stage:iic, dead, 369 days	207.0
TCGA-EB-A24D-01A	72 years, male, white, stage:iiib, alive, 645 days	205.1
TCGA-BF-AAP6-01A	55 years, male, white, stage:iii, alive, 325 days	203.7
TCGA-BF-A3DN-01A	81 years, female, white, stage:iiic, alive, 717 days	202.5
TCGA-EB-A44O-01A	69 years, male, white, stage:iib, alive, 81 days	200.9
TCGA-EB-A4OY-01A	65 years, female, white, stage:iiib, alive, 977 days	196.6
TCGA-GN-A4U5-01A	61 years, female, white, stage:ib, alive, 1156 days	192.2
TCGA-EB-A44P-01A	58 years, female, white, stage:iic, alive, 741 days	186.0
TCGA-EB-A51B-01A	53 years, male, white, stage:iic, alive, 931 days	184.8
TCGA-EB-A24C-01A	56 years, male, white, alive, 632 days	184.6
TCGA-BF-A1Q0-01A	80 years, male, white, stage:iic, alive, 831 days	181.8
TCGA-EB-A44N-01A	59 years, male, white, stage:iic, dead, 205 days	179.7
TCGA-EB-A3XF-01A	57 years, male, white, stage:iic, alive, 278 days	176.9
TCGA-BF-A5ES-01A	76 years, female, white, stage:iic, alive, 490 days	176.8
TCGA-D9-A4Z5-01A	68 years, male, white, stage:iib, alive, 218 days	176.6
TCGA-EB-A1NK-01A	48 years, male, white, stage:iic, alive, 1039 days	173.2
TCGA-BF-A3DM-01A	63 years, male, white, stage:iia, alive, 601 days	172.2
TCGA-D9-A3Z4-01A	54 years, male, white, stage:iiic, dead, 519 days	172.0
TCGA-BF-A1PZ-01A	71 years, female, white, stage:iib, alive, 853 days	166.1
TCGA-BF-AAP4-01A	61 years, male, white, stage:iic, alive, 335 days	158.4
TCGA-FR-A726-01A	90 years, male, white, stage:iic, dead, 305 days	157.7
TCGA-FS-A1ZN-01A	43 years, male, white, stage:iiia, dead, 730 days	154.1
TCGA-XV-A9W5-01A	51 years, male, white, stage:i/ii nos, alive, 392 days	150.3
TCGA-EB-A6QY-01A	71 years, male, white, stage:iic, alive, 382 days	148.3
TCGA-EB-A4IS-01A	77 years, male, white, stage:iib, alive, 774 days	147.9
TCGA-GN-A263-01A	24 years, male, white, stage:iv, dead, 467 days	139.6
TCGA-GN-A26C-01A	77 years, male, white, stage:iiic, dead, 821 days	136.5
TCGA-FR-A728-01A	54 years, female, white, stage:iiib, alive, 583 days	135.0
TCGA-WE-A8K4-01A	85 years, male, white, stage:iib, alive, 614 days	126.2
TCGA-FR-A2OS-01A	49 years, female, white, stage:iic, dead, 368 days	124.4
TCGA-EB-A3Y6-01A	56 years, female, white, stage:iic, alive, 126 days	113.7
TCGA-EB-A551-01A	78 years, female, white, stage:iiic, alive, 590 days	112.0
TCGA-EB-A41A-01A	90 years, male, white, stage:iic, alive, 262 days	107.6
TCGA-EB-A42Z-01A	49 years, male, asian, stage:iiic, alive, 441 days	101.9
TCGA-FR-A3R1-01A	69 years, male, white, stage:iic, alive, 685 days	100.7
TCGA-EB-A5FP-01A	65 years, female, white, stage:iv, dead, 454 days	92.8
TCGA-BF-A3DJ-01A	36 years, female, white, stage:iiib, alive, 464 days	92.0
TCGA-EB-A3XB-01A	63 years, male, white, stage:ii, alive, 796 days	90.0
TCGA-EB-A431-01A	34 years, male, white, stage:iic, alive, 568 days	81.0
TCGA-FW-A5DX-01A	71 years, male, white, stage:iiic, alive, 640 days	59.6
Show allShow less

MELANOMA - Protein expressionⁱ

Pending cancer tissue analysis